Free Republic 3rd Qtr 2025 Fundraising Target: $81,000 Receipts & Pledges to-date: $1,117
1%  
Woo hoo!! 3rd Qtr 2025 FReepathon is now underway!!

Keyword: regeneronpharma

Brevity: Headers | « Text »
  • Regeneron Halts Enrollment of Critically Ill Patients in COVID-19 Antibody Trial (Potential issues with this group)

    10/30/2020 2:16:31 PM PDT · by rxsid · 8 replies
    https://www.biospace.com ^ | 10.30.2020 | Brandon May
    Regeneron Halts Enrollment of Critically Ill Patients in COVID-19 Antibody TrialRegeneron Pharmaceuticals has decided to halt enrollment of very sick patients with COVID-19 in its trial studying antibody cocktail REGN-COV2... The decision to halt critically ill patients was made in response to Regeneron’s independent safety board finding a potential safety signal and an unfavorable risk-benefit profile of the monoclonal antibody therapy in a subgroup of patients requiring high-flow oxygen or mechanical ventilation. These patients are generally sicker and hospitalized because they are in the advanced stages of the disease. The Tarrytown, N.Y.-based pharmaceutical company says it is blinded to the...